Humana
682 hedge funds and large institutions have $34.9B invested in Humana in 2018 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 210 increasing their positions, 290 reducing their positions, and 68 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 15 → 20 (+5)
6% more capital invested
Capital invested by funds: $33B → $34.9B (+$1.89B)
1% more ownership
Funds ownership: 93.09% → 94.09% (+1%)
1% less first-time investments, than exits
New positions opened: 67 | Existing positions closed: 68
1% less funds holding
Funds holding: 691 → 682 (-9)
28% less repeat investments, than reductions
Existing positions increased: 210 | Existing positions reduced: 290
53% less call options, than puts
Call options by funds: $280M | Put options by funds: $600M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$672M |
| 2 |
JP Morgan Chase
New York
|
-$223M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$163M |
| 4 |
State Street
Boston,
Massachusetts
|
-$141M |
| 5 |
Millennium Management
New York
|
-$127M |
HUM Hedge Fund Activity: Q1 2018 in Review
682 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Humana (HUM) for Q1 2018, worth a combined $34.9B — up 5.7% from $33B a quarter earlier.
Sellers outnumbered buyers: 68 funds closed out of HUM and 67 opened new positions — a net loss of 1 holder — while 290 trimmed existing stakes and 210 added.
The largest buyer was Fidelity Investments, adding an estimated $442M. The largest seller was T. Rowe Price Associates, cutting an estimated $672M.
- 682 institutional investors held Humana (HUM) as of Q1 2018, down from 691 in Q4 2017.
- Funds reported $34.9B of Humana stock for Q1 2018, up 5.7% quarter-over-quarter.
- 67 funds opened new Humana positions in Q1 2018 and 68 closed out, a net change of -1 holder.
- The largest Humana buyer in Q1 2018 was Fidelity Investments, an estimated $442M added.
- The largest Humana seller in Q1 2018 was T. Rowe Price Associates, an estimated $672M sold.
Based on aggregated 13F filings for Q1 2018.